Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "Dow"

773 News Found

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network
Hospitals | April 20, 2026

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network

The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.


Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
Supply Chain | April 18, 2026

Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem

Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe


Salve Group launches Parasoft foot cream to address dry and cracked feet
News | April 17, 2026

Salve Group launches Parasoft foot cream to address dry and cracked feet

This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture


Beyond beds and buildings: The quiet capital shift reshaping healthcare
Opinion | April 17, 2026

Beyond beds and buildings: The quiet capital shift reshaping healthcare

The investment case for health technology in India is frequently overstated in one direction and understated in another


Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice
Healthcare | April 17, 2026

Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice

4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration


Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD
Biopharma | April 16, 2026

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD

TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility


Clean Cells, Naobios step up Asia expansion at BIO KOREA 2026 in Seoul
Biotech | April 16, 2026

Clean Cells, Naobios step up Asia expansion at BIO KOREA 2026 in Seoul

The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem


India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Biotech | April 16, 2026

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments